Heron Therapeutics (HRTX) Stock: Tumbling On FDA Rejection
Heron Therapeutics Inc (NASDAQ: HRTX) is having an overwhelmingly rough day in the market today, and for good reason. The company announced that the FDA has rejected a New Drug Application (NDA), upsetting investors who are sending the stock tumbling. Today, we’ll talk about: The FDA rejection; what we’re seeing from HRTX stock as a … Read more